Zero Childhood Cancer is a research initiative offering personalised medicine for children with high-risk or relapsed cancer.
The program will involve the detailed laboratory analysis of each child’s unique cancer cells, to help identify the drugs most likely to kill their specific cancer.
Scientists and doctors will then work collaboratively to identify and deliver the most effective treatment plan, specifically tailored to suit each child’s individual disease.
Personalised cancer therapy, tailored to each child’s cancer, with its own genetic characteristics and individual response to anti-cancer drugs, holds the exciting promise of one day pushing childhood cancer survival rates to 100%.
The program involves all paediatric oncology units across Australia. The Garvan Institute and the Kinghorn Centre are research partners of the program.
- Read more about the aims and details of the program.